TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bio-Works Sweden AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
44,468
|
39,135
|
21,419 |
Financial expenses |
2
|
19
|
0 |
Earnings before taxes |
-52,671
|
-39,533
|
-40,467 |
EBITDA |
-52,924
|
-39,880
|
-40,001 |
Total assets |
24,901
|
39,402
|
45,192 |
Current assets |
22,380
|
37,101
|
43,452 |
Current liabilities |
15,784
|
20,199
|
8,525 |
Equity capital |
9,117
|
19,203
|
36,666 |
- share capital |
101
|
95
|
98 |
Employees (average) |
33
|
35
|
27 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
36.6%
|
48.7%
|
81.1% |
Turnover per employee |
1,348
|
1,118
|
793 |
Profit as a percentage of turnover |
-118.4%
|
-101.0%
|
-188.9% |
Return on assets (ROA) |
-211.5%
|
-100.3%
|
-89.5% |
Current ratio |
141.8%
|
183.7%
|
509.7% |
Return on equity (ROE) |
-577.7%
|
-205.9%
|
-110.4% |
Change turnover |
2,556
|
18,360
|
14,312 |
Change turnover % |
6%
|
88%
|
201% |
Chg. No. of employees |
-2
|
8
|
0 |
Chg. No. of employees % |
-6%
|
30%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.